EXOZYMES INC. (EXOZ) Stock Profile — Insider Trades & Financials

Net Income-$2.7M

EPS$-0.78

Market Cap$87.4M

Price Performance

Historical data including institutional events

Loading price data...

Company Profile

Michael Heltzen

CEO & Executive Director

eXoZymes, Inc. operates as a development stage biotechnology company. The company focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California.

Founded: 2014
Employees: 31
Headquarters: Monrovia, California, United States
Website: www.exozymes.com

⚡

Core Efficiency

ROE?

-78.15%

ROA?

-44.46%

D/E Ratio?

0.76

📊

Profitability Ratios

Current Ratio?

2.51

Loading comparison...

Earnings Calendar

Filing history and next expected filing date

Next Expected Filing

Aug 28, 2026 (in 141 days)

Annual Report (10-K) — Estimated

Aug 28, 2026

Predicted10-K

Mar 30, 2026

10-KQ4 20251d after period end

Nov 13, 2025

10-QQ3 20250d after period end

Aug 12, 2025

10-QQ2 20250d after period end

May 12, 2025

10-QQ1 20250d after period end

Mar 31, 2025

10-KQ4 20240d after period end

Nov 12, 2024

10-QQ3 20240d after period end

Loading company sections...

EXOZYMES INC.

Price Performance

Company Profile

Core Efficiency

Profitability Ratios

Earnings Calendar

Core Efficiency

Profitability Ratios

Earnings Calendar

Data Freshness